Local Oncologist Publishes New Research on Lung Cancer

Rogers, AR, January 20, 2015 (Newswire.com) - Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), Northwest Arkansas’ leading cancer research group, recently collaborated with research published in the Journal of Thoracic Oncology (JTO).

The research focuses on a new treatment medley for patients diagnosed with advanced nonsquamous non-small-cell lung cancer. The research was initially published online on Nov. 26, 2014 and was published this month in JTO.

The Center for Chest Care has allowed lung cancer patients to participate in more clinical trials than any other community based program in the country.

J. Thaddeus Beck, Dr.

“The Center for Chest Care (CCC) and Highlands Cancer Center are committed to Team Building in cancer care,” Beck said. “The Center For Chest Care has met weekly for over twelve years for the sole purpose of providing the best treatment plan for lung cancer patients.”

“The Center for Chest Care has allowed lung cancer patients to participate in more clinical trials than any other community based program in the country,” Beck said. “Highlands  is extremely proud of the work and dedication of the physicians and staff at CCC. Publishing peer reviewed lung cancer research represents the pinnacle manifestation of work taking place at CCC." 

Lung cancer is a pervasive and deadly disease in the U.S. and the world. 

About 224,210 new cases of lung cancer, and 159,260 deaths resulting from lung cancer, were predicted for 2014 in the United States, according to the American Cancer Society. As such, continuous research on the treatment methods for lung cancer is paramount. 

Journal of Thoracic Oncology, the official Journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies, according to the journal’s website. JTO emphasizes a multidisciplinary approach, and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces.

Read more on the study at: http://www.ncbi.nlm.nih.gov/pubmed/25371077

###

Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.

For more information visit www.HighlandsOncologyGroup.com.